Non-invasive and Continuous Blood Pressure Monitoring

Not yet recruiting

• Conditions: Blood Pressure

• Registration Number: NCT06887465
• Lead Sponsor: Vena Vitals

Brief Summary

The goal of this observational study is to evaluate the accuracy and reliability of the VeriTrack non-invasive blood pressure monitor compared to radial arterial catheterization in adult surgical patients.

The main question it aims to answer is:

How well does VeriTrack measure continuous blood pressure compared to an arterial catheter?

Researchers will compare VeriTrack readings to arterial line measurements to determine if the VeriTrack provides comparable accuracy and clinical utility.

Participants will wear the VeriTrack device during surgery and have a radial arterial catheter placed as part of standard care.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-03
• Study First Submitted: 2025-03-13
• Study First Submitted QC: 2025-03-13
• Study First Posted: 2025-03-20
• Last Update Submitted: 2025-03-31
• Last Update Posted: 2025-04-03
• Study Start: 2025-06
• Primary Completion: 2025-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients whose blood pressure will be monitored using an arterial line during their procedure
• Patients who have a palpable dorsalis pedis pulse

Exclusion Criteria

• Patients who have non-palpable dorsalis pedis pulses
• Patients whose limbs are inaccessible for placement of Vena Vitals Wearable
• Patients with known allergy to adhesives and/or silicone

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Accuracy of the VeriTrack device in continuous blood pressure monitoring	1-24 hours	Systolic, diastolic, and mean arterial pressure (MAP) values will be compared between the VeriTrack and the arterial line using a Bland-Altman analysis.

Secondary Outcome Measures

Name	Time	Method
Blood Pressure Change Accuracy	1-24 hours	Changes in sys, dia, and MAP measured by VeriTrack will be evaluated and compared to the changes measured by the arterial line

Trial Locations

Locations (1)

Thomas Jefferson University; 🇺🇸 Philadelphia, Pennsylvania, United States